- Home
- TRNO vs PTCT Comparison
TRNO vs PTCT Comparison
Compare TRNO & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRNO | PTCT |
|---|---|---|
| Founded | 2009 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.3B |
| IPO Year | 2010 | 2013 |
Fundamental Metrics
Financial Performance| Metric | TRNO | PTCT |
|---|---|---|
| Price | $59.08 | $77.41 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 17 |
| Target Price | $65.08 | ★ $73.76 |
| AVG Volume (30 Days) | 640.0K | ★ 1.1M |
| Earning Date | 02-04-2026 | 02-26-2026 |
| Dividend Yield | ★ 3.53% | N/A |
| EPS Growth | ★ 75.67 | N/A |
| EPS | 3.15 | ★ 8.94 |
| Revenue | $442,611,000.00 | ★ $1,779,150,000.00 |
| Revenue This Year | $22.96 | $127.32 |
| Revenue Next Year | $10.44 | N/A |
| P/E Ratio | $18.71 | ★ $8.58 |
| Revenue Growth | 21.13 | ★ 97.54 |
| 52 Week Low | $48.18 | $35.95 |
| 52 Week High | $69.20 | $87.50 |
Technical Indicators
Market Signals| Indicator | TRNO | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 41.37 | 50.87 |
| Support Level | $57.95 | $74.22 |
| Resistance Level | $59.85 | $80.20 |
| Average True Range (ATR) | 1.08 | 2.13 |
| MACD | -0.18 | -0.22 |
| Stochastic Oscillator | 35.83 | 44.24 |
Price Performance
Historical ComparisonAbout TRNO Terreno Realty Corporation
Terreno Realty Corp is a real estate investment trust engaged in acquiring, owning, and operating industrial real estate in six coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. The company invests in several types of industrial real estate, including warehouse/distribution, flex (including light industrial and research and development), transshipment, and improved land.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.